logo

For the Inventor, By the Inventor

New York, NY, United States of America

Memorial Sloan Kettering Cancer Center


USPTO Granted Patents = 560



Trademarks = 19

Forward Citations = 2,469

Loading Chart...
Loading Chart...

798 inventors (with patents filed for the assignee):

goldMedal Taha Merghoub (42 out of 42 patents)

silverMedal Jedd David Wolchok (33 out of 35 patents)

bronzeMedal Gerd J Ritter (31 out of 58 patents)

4.  Michel Sadelain (30 out of 34 patents)

5.  Cheng Liu (27 out of 46 patents)

6.  David Schaer (26 out of 26 patents)

7.  Thomas Fuchs (26 out of 82 patents)

8.  Nai-Kong V Cheung (26 out of 49 patents)

9.  Marc A Van Dijk (26 out of 42 patents)

10.  Lloyd J Old (23 out of 122 patents)

11.  David A Scheinberg (23 out of 49 patents)

12.  Nicholas Stuart Wilson (22 out of 35 patents)

13.  Lorenz Studer (20 out of 23 patents)

14.  Renier J Brentjens (19 out of 19 patents)

15.  Eric L Smith (17 out of 85 patents)


Core Competencies:
Immunotherapy
Chimeric Antigen Receptors
Cancer Treatment
Biomedical Imaging
T Cell Therapy
Histopathology
Nanotherapeutics
Robotic Surgery
Antibody Therapy
Stem Cell Modulation
Multi-Task Learning
Contrastive Loss

560 patents:

1. 12511861 - Detection of annotated regions of interest in images (2025-12-30),
2. 12485162 - Determinants of cancer response to immunotherapy by pd-1 blockade (2025-12-02),
3. 12462921 - Universal slide viewer (2025-11-04),
4. 12453888 - Supine stepper (2025-10-28),
5. 12450735 - Learning representations of nuclei in histopathology images with contrastive loss (2025-10-21),
6. 12441793 - CD33 antibodies and methods of using the same to treat cancer (2025-10-14),
7. 12441789 - DLL3-targeting antibodies and uses thereof (2025-10-14),
8. 12435156 - Methods for treating neuroblastoma with combination therapy (2025-10-07),
9. 12435088 - Salicyl-adenosinemonosulfamate analogs and uses thereof (2025-10-07),
10. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),
11. 12414969 - Methods and compositions for reducing clostridium difficile infection (2025-09-16),
12. 12409171 - Pharmaceutically active pyrazolo-pyridone modulators of DCN1/2-mediated cullin neddylation (2025-09-09),
13. 12406511 - Determining scores indicative of times to events from biomedical images (2025-09-02),
14. 12404489 - Establishing topographic organization in three-dimensional tissue culture (2025-09-02),
15. 12404316 - Transgenic T cell and chimeric antigen receptor T cell compositions and related methods (2025-09-02),
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned comprehensive cancer center located in New York City. It is dedicated to patient care, research, and education in the field of oncology. MSKCC provides cutting-edge treatments and personalized care for all types of cancer. With a team of highly skilled physicians, scientists, and healthcare professionals, MSKCC strives to advance cancer prevention, diagnosis, and treatment through innovative research and clinical trials. Their mission is to lead in translating research discoveries into new, effective therapies for cancer patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
560 Patents

#27 in New York, NY

#51 in New York

#844 in US

#1,689 in the World

...
New York, NY, United States of America

Memorial Sloan Kettering Cancer Center

Forward Citations = 2,469

798 inventors:

goldMedal Taha Merghoub (42 out of 42 patents)

silverMedal Jedd David Wolchok (33 out of 35 patents)

bronzeMedal Gerd J Ritter (31 out of 58 patents)

4.  Michel Sadelain (30 out of 34 patents)

5.  Cheng Liu (27 out of 46 patents)

Please report any incorrect information to support@idiyas.com
Loading…